These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36911073)

  • 1. Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation.
    Huang J; Lin Z; Wang Y; Ding X; Zhang B
    Drug Des Devel Ther; 2023; 17():675-690. PubMed ID: 36911073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia.
    Qian Y; Yin J; Ni J; Chen X; Shen Y
    Biomed Res Int; 2023; 2023():2507683. PubMed ID: 36817858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential molecular mechanisms of Ermiao san in the treatment of hyperuricemia and gout based on network pharmacology with molecular docking.
    Geng YH; Yan JH; Han L; Chen Z; Tu SH; Zhang LQ; Song CD; Duan FY; Liu YF
    Medicine (Baltimore); 2022 Sep; 101(37):e30525. PubMed ID: 36123941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
    Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
    Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.
    Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y
    Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice.
    Xu L; Cheng J; Lu J; Lin G; Yu Q; Li Y; Chen J; Xie J; Su Z; Zhou Q
    Front Pharmacol; 2022; 13():964593. PubMed ID: 36438835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing the mechanism of "Huai Hua San" in the treatment of ulcerative colitis based on network pharmacology and experimental study.
    Chen PY; Yuan C; Hong ZC; Zhang Y; Ke XG; Yu B; Wang C; Xiao XC; Wu HZ; Yang YF
    J Ethnopharmacol; 2021 Dec; 281():114321. PubMed ID: 34118340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments.
    Fan L; Guo Y; Wu Q; Hu T; Chen X; Guo J; Liu Y; Lu Y; Lin M
    Evid Based Complement Alternat Med; 2023; 2023():6931644. PubMed ID: 36865745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the Potential Mechanism of Tonifying Kidney and Removing Dampness Formula in the Treatment of Postmenopausal Dyslipidemia Based on Network Pharmacology, Molecular Docking and Experimental Evidence.
    Li X; Chen H; Yang H; Liu J; Li Y; Dang Y; Wang J; Wang L; Li J; Nie G
    Front Endocrinol (Lausanne); 2022; 13():918469. PubMed ID: 35872979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The active components and potential mechanisms of Wuji Wan in the treatment of ethanol-induced gastric ulcer: An integrated metabolomics, network pharmacology and experimental validation.
    Wu T; Zhang H; Jin Y; Zhang M; Zhao Q; Li H; Wang S; Lu Y; Chen S; Du H; Liu T; Guo W; Liu W
    J Ethnopharmacol; 2024 May; 326():117901. PubMed ID: 38341112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the substance basis and pharmacological mechanism of Fufang Qiling granules in modulating xanthine oxidase for intervention in hyperuricemia.
    Ye J; Yao J; Xu S; Xiao G; Jia Y; Xie N; Yan J; Ying X; Zhang H
    J Ethnopharmacol; 2024 Oct; 333():118410. PubMed ID: 38848973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study on the material basis and mechanism underlying uric acid reduction by Thlaspi arvense L.
    Ke X; Yang X; Hou C; Wang Y; Zhou Y; Wu T; Yang R
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):116814. PubMed ID: 37598767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis.
    Wu N; Yuan T; Yin Z; Yuan X; Sun J; Wu Z; Zhang Q; Redshaw C; Yang S; Dai X
    Drug Des Devel Ther; 2022; 16():435-466. PubMed ID: 35221674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated study of Shenling Baizhu San against hyperuricemia: Efficacy evaluation, core target identification and active component discovery.
    Wang Y; Lin ZJ; Huang J; Chu MZ; Ding XL; Li WJ; Mao QY; Zhang B
    J Ethnopharmacol; 2022 Sep; 295():115450. PubMed ID: 35688256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Response and Oxidative Stress as Mechanism of Reducing Hyperuricemia of
    Liu L; Jiang S; Liu X; Tang Q; Chen Y; Qu J; Wang L; Wang Q; Wang Y; Wang J; Zhang Y; Kang W
    Oxid Med Cell Longev; 2021; 2021():8031319. PubMed ID: 34917234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated plasma pharmacochemistry and network pharmacology to explore the mechanism of Gerberae Piloselloidis Herba in treatment of allergic asthma.
    Zhou K; Lu D; You J; Liu T; Sun J; Lu Y; Pan J; Li Y; Liu C
    J Ethnopharmacol; 2022 Nov; 298():115624. PubMed ID: 35970314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.